WELLINGTON MANAGEMENT GROUP LLP - PDL BIOPHARMA INC ownership

Back to all holdings Add to watchlist

PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 153 filers reported holding PDL BIOPHARMA INC in Q4 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.

Links
Filings
External links
Quarter-by-quarter ownership
WELLINGTON MANAGEMENT GROUP LLP ownership history of PDL BIOPHARMA INC
ValueSharesWeighting
Q3 2018$558,000
-84.1%
212,287
-85.9%
0.00%
-100.0%
Q2 2018$3,516,000
-20.5%
1,502,485
-0.0%
0.00%0.0%
Q1 2018$4,420,000
+10.6%
1,503,153
+3.0%
0.00%0.0%
Q4 2017$3,998,000
-19.2%
1,459,1330.0%0.00%0.0%
Q3 2017$4,947,000
+30.4%
1,459,133
-5.0%
0.00%0.0%
Q2 2017$3,794,000
+5.4%
1,535,837
-3.1%
0.00%0.0%
Q1 2017$3,599,000
+6.7%
1,585,544
-0.4%
0.00%0.0%
Q4 2016$3,374,000
-24.5%
1,591,250
+19.3%
0.00%0.0%
Q3 2016$4,467,000
+6.8%
1,333,446
+0.1%
0.00%0.0%
Q2 2016$4,184,000
-5.7%
1,332,5040.0%0.00%0.0%
Q1 2016$4,437,000
-5.9%
1,332,5040.0%0.00%0.0%
Q4 2015$4,717,000
+9.1%
1,332,504
+55.0%
0.00%0.0%
Q3 2015$4,325,000
-14.3%
859,797
+9.5%
0.00%0.0%
Q2 2015$5,049,000
+4.9%
785,309
+14.7%
0.00%0.0%
Q1 2015$4,815,000
+21.0%
684,467
+32.7%
0.00%0.0%
Q4 2014$3,978,000
+5.7%
515,955
+2.4%
0.00%0.0%
Q3 2014$3,763,000
+26.1%
503,734
+63.4%
0.00%0.0%
Q2 2014$2,984,000
-50.2%
308,200
-57.3%
0.00%
-50.0%
Q1 2014$5,995,000
+3.7%
721,435
+5.3%
0.00%0.0%
Q4 2013$5,783,000
+21.8%
685,135
+15.1%
0.00%
+100.0%
Q3 2013$4,746,000
+10.1%
595,435
+6.7%
0.00%0.0%
Q2 2013$4,309,000–558,135–0.00%–
 Download
Other shareholders
PDL BIOPHARMA INC shareholders Q4 2018
NameSharesValueWeighting ↓
Argent Trust Co 41,405$102,2700.01%
Diversified Trust Co 11,029$26,4690.00%
HANCOCK WHITNEY CORP 128,396$00.00%
RHUMBLINE ADVISERS 612$1,5110.00%
Ancora Advisors LLC 4,948$00.00%
Westside Investment Management, Inc. 500$00.00%
View complete list of PDL BIOPHARMA INC shareholders